![Cheryl Gault](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 6 M $ al 30/06/2026
Cheryl Gault is currently Chief Operating Officer at Rapport Therapeutics, Inc. since 2023.
Formerly, Ms. Gault was Chief Operating Officer at Cyclerion Therapeutics, Inc. from 2021 to 2023, VP-Commercial Strategy & New Product Planning at Ironwood Pharmaceuticals, Inc. from 2017 to 2019, and held the position Head-Sales & Marketing at Genzyme Corp.
Ms. Gault completed undergraduate education at Boston College.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/06/2026 | 149.914 ( 0,31 % ) | 6 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| RAPPORT THERAPEUTICS, INC. | Director de Operaciones | 07/09/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Director de Operaciones | 28/07/2023 |
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2019 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Ventas & Marketing | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Ironwood Pharmaceuticals, Inc.
 Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cyclerion Therapeutics, Inc.
 Cyclerion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products for serious and orphan diseases | Health Technology |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
